0001209191-21-060022.txt : 20211008
0001209191-21-060022.hdr.sgml : 20211008
20211008160019
ACCESSION NUMBER: 0001209191-21-060022
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210930
FILED AS OF DATE: 20211008
DATE AS OF CHANGE: 20211008
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: PASSERI DANIEL R
CENTRAL INDEX KEY: 0001190121
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38327
FILM NUMBER: 211315310
MAIL ADDRESS:
STREET 1: C/O CURIS INC
STREET 2: 4 MAGUIRE ROAD
CITY: LEXINGTON
STATE: MA
ZIP: 02421
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cue Biopharma, Inc.
CENTRAL INDEX KEY: 0001645460
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 473324577
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 21 ERIE STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-949-2680
MAIL ADDRESS:
STREET 1: 21 ERIE STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: Imagen Biopharma, Inc.
DATE OF NAME CHANGE: 20150617
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-09-30
0
0001645460
Cue Biopharma, Inc.
CUE
0001190121
PASSERI DANIEL R
C/O CUE BIOPHARMA, INC.
21 ERIE STREET
CAMBRIDGE
MA
02139
1
1
0
0
CHIEF EXECUTIVE OFFICER
Common Stock
2021-09-30
4
M
0
75000
A
130377
D
Common Stock
2021-09-30
4
F
0
31677
14.57
D
98700
D
Restricted Stock Units
2021-09-30
4
M
0
75000
0.00
D
Common Stock
75000
75000
D
Represents shares of common stock received upon vesting of a restricted stock unit award.
Each restricted stock unit award represents a contingent right to receive one share of common stock.
One half of the Restricted Stock Units vested on September 30, 2021 and the balance will vest on March 31, 2022.
/s/ Daniel Passeri by Colin Sandercock, attorney-in-fact
2021-10-08